Latvia - Hospital Average Length of Stay for Malignant Neoplasm of Bladder
Since 2014, Latvia Hospital Average Length of Stay for Malignant Neoplasm of Bladder was down by 0.9% year on year. In 2019, the country was number 9 comparing other countries in Hospital Average Length of Stay for Malignant Neoplasm of Bladder with 6.6 Days. Latvia is overtaken by Chile, which was ranked number 8 with 6.7 Days and is followed by Czech Republic at 6.3 Days. South Korea topped the ranking with 11.3 Days in 2019, stable compared to 2018. Iceland recorded the best 5 years average growth at +6.9% per year, while Mexico witnessed the worst performance at -5% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 6.60 |
| 2018 | 6.50 |
| 2017 | 7.10 |
| 2016 | 6.50 |
| 2015 | 6.70 |
Download all data from 2013 to 2019
How does Latvia rank in Hospital Average Length of Stay for Malignant Neoplasm of Bladder?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
11.30 | 2019 | +0.0 % | +0.7 % | View data | |
| 2 |
#2
Iceland
|
8.50 | 2019 | +2.4 % | +6.9 % | View data | |
| 8 |
#8
Chile
|
6.70 | 2019 | -4.3 % | -2.2 % | View data | |
| 9 |
#9
Latvia
|
6.60 | 2019 | +1.5 % | -0.9 % | View data | |
| 10 |
#10
Czech Republic
|
6.30 | 2019 | +0.0 % | -1.2 % | View data | |